A Study of SC-007 in Subjects With Advanced Cancer
Status:
Terminated
Trial end date:
2018-04-02
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC)
or gastric cancer to study the safety and tolerability of SC-007 and consists of Part A (dose
regimen finding) in participants with CRC followed by Part A in participants with gastric
cancer. Part B (dose expansion) will enroll participants into separate disease specific
cohorts of CRC or gastric cancer.